Tyra Biosciences, Inc.TYRANASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P52
Within normal range
vs 3Y Ago
-2.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.63% |
| Q3 2025 | 5.45% |
| Q2 2025 | 6.91% |
| Q1 2025 | -29.99% |
| Q4 2024 | -9.17% |
| Q3 2024 | -67.32% |
| Q2 2024 | 51.60% |
| Q1 2024 | -56.80% |
| Q4 2023 | 17.95% |
| Q3 2023 | -78.38% |
| Q2 2023 | 2.33% |
| Q1 2023 | 17.61% |
| Q4 2022 | 2.11% |
| Q3 2022 | 29.62% |
| Q2 2022 | -90.08% |
| Q1 2022 | -0.34% |
| Q4 2021 | -56.55% |
| Q3 2021 | -24.10% |
| Q2 2021 | 0.78% |
| Q1 2021 | -82.44% |
| Q4 2020 | -16.82% |
| Q3 2020 | -29.77% |
| Q2 2020 | -11.09% |
| Q1 2020 | 0.00% |